Cambria Global Value ETF (GVAL)
Live price chart, market sentiment, and community perspectives for Cambria Global Value ETF (CBOE: GVAL).
Live price chart, market sentiment, and community perspectives for Cambria Global Value ETF (CBOE: GVAL).
On our desk, evaluating GVAL feels a lot like debating whether a cyclical value rotation has finally broken its multi-year secular hibernation. While the fund delivered a striking 56% return last year and solid 12-month momentum, its long-term annualized CAGR since inception sits at a modest 5.92%. For a portfolio holding 113 to 129 companies with a heavy financials tilt, the structural appeal of its CAPE-based country selection is undeniable, but it still lags behind peer value vehicles like DFIV and IVLU over extended horizons.
From a risk management perspective, GVAL carries a Morningstar portfolio risk score of 87, flagging it as Very Aggressive—essentially matching broad developed-market equity risk rather than serving as a conservative sleeve. Its 10-year downside capture of 102 and a worst 10-year drawdown of -39.4% indicate that it absorbs substantially more pain during prolonged bear markets compared to category norms, even though its recent 3-year downside capture has improved down to 51.
When analyzing execution friction for our clients, GVAL presents a distinct operational hurdle. Despite a reasonable total expense ratio of 0.66% for an actively managed fund, the liquidity profile is concerning. With a bid-ask spread floating between 36 and 64 basis points, frequent trading, rebalancing, or dollar-cost-averaging becomes remarkably expensive. Long-term patience measured strictly in years is an absolute prerequisite before deploying capital here.
As a quant reviewing factor exposures, GVAL's underlying strategy uses a dual-layer approach: first identifying the cheapest countries globally using cyclically adjusted price-earnings ratios, and then picking the cheapest stocks within those borders using traditional metrics. While the 1-year return of roughly 45% highlights the potency of this strategy during favorable cycles, its Morningstar Neutral Medalist Rating reflects a balanced view of its repeatable process against its inconsistent historical alpha.
Watching the macro shifts in early 2026, the overall market environment is finally tilting away from the 'growth at any price' regime that dominated since the mid-2010s. Value trades are showing life, with the Russell 1000 Value Index ticking up while growth indexes stumble. GVAL benefits directly from this sentiment shift as it targets undervalued ex-U.S. markets, though its emerging market allocations introduce structural geopolitical and currency vulnerabilities that demand careful position sizing.
Explore plasma cleansing, somatic organ swaps, and BCI.